Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results